Cargando…
Retracted: Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726256/ https://www.ncbi.nlm.nih.gov/pubmed/36482933 http://dx.doi.org/10.1155/2022/9791408 |
Ejemplares similares
-
Retracted: Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: A Comprehensive Nursing Model Combined with High-Quality Nursing Intervention for Antiviral Therapy in Patients with Chronic Hepatitis B
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of the B2M Expression in Colon Adenocarcinoma and Its Correlation with Patient Prognosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)